MedPath

Changes of Biomarkers in Response to Training and Antioxidant Treatment

Phase 1
Completed
Conditions
Obesity
Type 2 Diabetes
Interventions
Dietary Supplement: Vitamin C, Vitamin E
Dietary Supplement: Antioxidant treatment
Registration Number
NCT00638560
Lead Sponsor
University of Leipzig
Brief Summary

The aim of the study is to compare the effects of an intensive 4 weeks exercise training program with or without additional treatment with antioxidants. 16 volunteers are included into the study and randomized into a treatment (n=8,Vitamine E 400 IU od + vitamine C 1g twice daily) and a non-treatment (n=8, training only) group. Before and after the training program, skeletal muscle biopsies will be taken to measure PGC-1alpha and PPARgamma mRNA expression. In addition before and after the training program individuals will have the following measurements: body weight, waist circumference, body fat content (DEXA scan), euglycemic-hyperinsulinemic clamps, ergospirometer (VO2 max), routine laboratory measurements, serum malondialdehyde concentrations.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
40
Inclusion Criteria
  • Must be able to swallow tablets
  • signed informed consent
  • no concommitant medication
  • male
  • age between 25 - 35 years
Exclusion Criteria
  • drug, tobacco or alcohol abuse
  • any chronic disease
  • any acute or chronic inflammatory disease as determined by a leucocyte count > 7000 Gpt/l, C-reactive protein (CrP) > 5.0 mg/dl or clinical signs of infection
  • systolic blood pressure (SBP) > 140mmHg and diastolic blood pressure (DBP) was > 85mmHg
  • cardiovascular or peripheral artery disease
  • thyroid dysfunction

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1Vitamin C, Vitamin EAntioxidant treatment arm: Vitamin E, 400 IU po, once daily Vitamin C, 1g po, twice daily
2Antioxidant treatmentControl
Primary Outcome Measures
NameTimeMethod
PGC-1alpha mRNA expression in skeletal muscle PPARgamma mRNA expression in skeletal muscle Serum malondialdehyde concentrationafter 4 weeks
Secondary Outcome Measures
NameTimeMethod
body weight glucose infusion rate during the steady state of an euglycemic-hyperinsulinemic clamp VO2max4 weeks

Trial Locations

Locations (1)

University of Leipzig

🇩🇪

Leipzig, Germany

© Copyright 2025. All Rights Reserved by MedPath